BioCentury
ARTICLE | Company News

Orgenesis, Tel Hashomer Medical Research Infrastructure and Services Ltd. deal

April 16, 2012 7:00 AM UTC

Tel Hashomer will begin a trial to evaluate functional autologous insulin-producing cells (AIPC) regeneration technology as a therapy for diabetes under the supervision of Orgenesis. The trial will be...